BE890796A - Composition pharmaceutique pour administration par voie orale contenant de la cytidine-diphosphocholine - Google Patents

Composition pharmaceutique pour administration par voie orale contenant de la cytidine-diphosphocholine

Info

Publication number
BE890796A
BE890796A BE0/206294A BE206294A BE890796A BE 890796 A BE890796 A BE 890796A BE 0/206294 A BE0/206294 A BE 0/206294A BE 206294 A BE206294 A BE 206294A BE 890796 A BE890796 A BE 890796A
Authority
BE
Belgium
Prior art keywords
diphosphocholine
pharmaceutical composition
oral administration
administration containing
containing cytidine
Prior art date
Application number
BE0/206294A
Other languages
English (en)
Inventor
E Borgo
Original Assignee
Made Italiana Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Made Italiana Srl filed Critical Made Italiana Srl
Publication of BE890796A publication Critical patent/BE890796A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/206294A 1980-04-18 1981-10-20 Composition pharmaceutique pour administration par voie orale contenant de la cytidine-diphosphocholine BE890796A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8048454A IT1207106B (it) 1980-04-18 1980-04-18 Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale

Publications (1)

Publication Number Publication Date
BE890796A true BE890796A (fr) 1982-02-15

Family

ID=11266633

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/206294A BE890796A (fr) 1980-04-18 1981-10-20 Composition pharmaceutique pour administration par voie orale contenant de la cytidine-diphosphocholine

Country Status (15)

Country Link
US (1) US4386077A (fr)
AT (1) AT376366B (fr)
AU (1) AU544469B2 (fr)
BE (1) BE890796A (fr)
CH (1) CH652026A5 (fr)
DE (1) DE3115080C2 (fr)
DK (1) DK173081A (fr)
ES (1) ES502080A0 (fr)
FR (1) FR2480603B1 (fr)
GB (1) GB2074445B (fr)
IN (1) IN156105B (fr)
IT (1) IT1207106B (fr)
NL (1) NL8101899A (fr)
SE (1) SE447449B (fr)
ZA (1) ZA812600B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569929A (en) * 1980-02-29 1986-02-11 Massachusetts Institute Of Technology Cytidyl diphosphocholine-drug composition
EP0114577A1 (fr) * 1983-01-21 1984-08-01 MAGIS FARMACEUTICI S.p.A. Composition pharmaceutique
IT1201474B (it) * 1985-10-01 1989-02-02 Vincenzo Zappia Derivati macromolecolarizzati di cdp-colina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
CA2094217A1 (fr) * 1992-04-17 1993-10-18 Yasutaka Igari Composition therapeutique transmucosale
US5872108A (en) * 1995-03-06 1999-02-16 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU2005201251B2 (en) * 1995-03-06 2006-04-27 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU1640400A (en) * 1995-03-06 2000-04-20 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
WO1996027380A1 (fr) * 1995-03-06 1996-09-12 Interneuron Pharmaceuticals, Inc. Reduction de l'ampleur des infarctus par la citicoline
US8030294B2 (en) * 2000-03-16 2011-10-04 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
US20060189566A1 (en) * 2003-02-26 2006-08-24 Miho Komatsu Muscle building agent and preventive or remedy for muscle weakening
WO2005122767A1 (fr) * 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, notamment de l'uridine, utilisees dans des traitements sur des patients atteints de troubles bipolaires
EP1765364A4 (fr) * 2004-06-10 2010-09-22 Mclean Hospital Corp Pyrimidines, tels que cytidine, dans les traitements de patients souffrant de troubles bipolaires
WO2006020703A1 (fr) * 2004-08-11 2006-02-23 The Mclean Hospital Corporation Compose pour le traitement de la dependance, de la suppression et de l'usage de la marijuana
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666748A (en) * 1967-12-18 1972-05-30 Takeda Chemical Industries Ltd Method for production of cytidine (or deoxycytidine)-5{40 -diphosphate choline and intermediates therefor
NL149812B (nl) * 1969-04-24 1976-06-15 Takeda Chemical Industries Ltd Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van kristallijn cytidine-5'-difosfaat-choline-monohydraat.
JPS4841555B1 (fr) * 1969-08-04 1973-12-07
JPS4886869A (fr) * 1972-02-23 1973-11-15

Also Published As

Publication number Publication date
AU544469B2 (en) 1985-05-30
DK173081A (da) 1981-10-19
GB2074445B (en) 1983-09-07
ES8207184A1 (es) 1982-09-01
DE3115080A1 (de) 1982-02-25
ES502080A0 (es) 1982-09-01
IT1207106B (it) 1989-05-17
AT376366B (de) 1984-11-12
ZA812600B (en) 1982-04-28
FR2480603A1 (fr) 1981-10-23
SE8102456L (sv) 1981-10-19
FR2480603B1 (fr) 1985-07-12
GB2074445A (en) 1981-11-04
IN156105B (fr) 1985-05-18
ATA172081A (de) 1984-04-15
CH652026A5 (it) 1985-10-31
NL8101899A (nl) 1981-11-16
IT8048454A0 (it) 1980-04-18
SE447449B (sv) 1986-11-17
AU6994581A (en) 1981-10-22
DE3115080C2 (de) 1986-10-16
US4386077A (en) 1983-05-31

Similar Documents

Publication Publication Date Title
BE849632A (fr) Composition pharmaceutique pour l'administration orale
FR2523443B1 (fr) Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
FR2530625B1 (fr) Derives d'indole, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
DZ1077A1 (fr) Nouvelles préparation pharmaceutique pour administration orale.
OA07124A (fr) Dipeptides substitués, procédés pour leur préparation et compositions pharmaceutiques les contenant et leur utilisation pour l'inhibition de l'encéphalinase.
BE879487A (fr) Comprimes pharmaceutique pour une application par voie orale et son procede de preparation
BE890574A (fr) Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant
ES272449Y (es) Unidad farmaceutica de administracion local.
DE19975062I1 (de) Pharmazeutische Zusammensetzungen die N-substituierte 3-Hydroxypyrid-2-on-oder-4-on-Derivate enthalten
FR2480603B1 (fr) Composition pharmaceutique pour administration par voie orale contenant de la cytidine-diphosphocholine
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
IT8147821A0 (it) Di sostanze medicamentose dispositivo per la somministrazione
BE845709R (fr) Composition pharmaceutique contenant du 1, 3-bis (2-carboxychromone-5-yloxy)-2-hydroxypropane pour le traitement de l'ulcere de la bouche
FR2585953B1 (fr) Composition pharmaceutique pour l'administration orale contenant de l'ubiquinone et procede
FR2580649B1 (fr) (-) - 1b - ethyl - 1a - hydroxymethyl -1,2,3,4,6,7,12,12ba-octahydroindolo(2,3-a) quinolizine, procede pour la preparer et compositions pharmaceutiques contenant celle-ci
PT77751A (fr) Procede de preparation de derives benzylideniques soufres et de compositions pharmaceutiques le contenant
FR2513994B1 (fr) Tripeptides anorexigenes, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2315910A1 (fr) Compositions pharmaceutiques contenant de la " debrycine " heterocolloidale et procede pour leur preparation
BE872647A (fr) Composition pharmaceutique administrable par voie orale
PT77767A (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
FR2529550B1 (fr) Derives d'acide apovincaminique, procede pour leur preparation et compositions pharmaceutiques contenant ces derives
FR2592043B1 (fr) 2-chloro-12-(3-dimethylamino-2-methylpropyl)-12h-dibenzo-(d, g) (1, 3, 6)-dioxazocines optiquement actives, procede pour leur preparation et compositions pharmaceutiques les contenant
BE810385A (fr) Compositions medicamenteuses pour l'administration par voie orale
FR2541114B1 (fr) Compositions pharmaceutiques antifongiques utilisables par voie orale contenant de l'omoconazole

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MADE ITALIANA S.R.L.

Effective date: 19901031